Abcellera Biologics Inc (ABCL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 12-2018 | 03-2001 | 12-2000 | |
| Sales | 4,657 | 0 | 0 | 24,610 | 27,140 |
| Gross Profit | 4,657 | N/A | N/A | N/A | N/A |
| Operating Expenses | 6,779 | 0 | 0 | 0 | 0 |
| Operating Income | -2,122 | N/A | N/A | N/A | N/A |
| Other Income | 29 | 0 | 0 | 24,610 | 27,140 |
| Pre-tax Income | -2,093 | 0 | 0 | 24,610 | 27,140 |
| Net Income Continuous | -2,093 | N/A | N/A | 24,610 | 27,140 |
| Net Income | $-2,093 | $N/A | $N/A | $24,610 | $27,140 |
| EPS Basic Total Ops | -0.01 | N/A | N/A | N/A | N/A |
| EPS Basic Continuous Ops | -0.01 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | -0.01 | N/A | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | -0.01 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-1,476 | $N/A | $N/A | $N/A | $N/A |